Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Discontinuation Patterns and Cost Avoidance of a Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus Nasal Polymerase Chain Reaction Testing Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia. Open forum infectious diseases Meng, L., Pourali, S., Hitchcock, M. M., Ha, D. R., Mui, E., Alegria, W., Fox, E., Diep, C., Swayngim, R., Chang, A., Banaei, N., Deresinski, S., Holubar, M. 2021; 8 (4): ofab099

Abstract

A pharmacist-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal polymerase chain reaction (PCR)-based testing protocol with a 70% acceptance rate for vancomycin discontinuation within 24 hours of negative results significantly reduced unnecessary vancomycin use with an estimated cost avoidance of $40 per vancomycin course. We found high concordance (141 of 147, 96%) of culture-based versus PCR-based MRSA nasal screening.

View details for DOI 10.1093/ofid/ofab099

View details for PubMedID 34386545

View details for PubMedCentralID PMC8355456